Quotes 5-day view Delayed Nasdaq Omx Stockholm
01/13/2021
01/14/2021
01/15/2021
01/18/2021
01/19/2021
Date
157.8(c)
159.25(c)
160(c)
162(c)
163.3(c)
Last
898 855
930 192
544 492
543 461
503 694
Volume
+1.28% +0.92% +0.47% +1.25% +0.80% Change
Sales 2020
15 321 M 1 837 M 1 837 M
Net income 2020
2 783 M 334 M 334 M
Net Debt 2020
11 157 M 1 338 M 1 338 M
P/E ratio 2020
17,4x
Yield 2020
-
Sales 2021
16 228 M 1 946 M 1 946 M
Net income 2021
3 119 M 374 M 374 M
Net Debt 2021
6 400 M 768 M 768 M
P/E ratio 2021
15,5x
Yield 2021
-
Capitalization
48 157 M 5 766 M 5 775 M
EV / Sales 2020
3,87x
EV / Sales 2021
3,36x
Nbr of Employees
1 471
Free-Float
61,3%
Swedish Orphan Biovitrum AB is specialized in the development, manufacturing and marketing of therapeutic products intended for the treatment of rare diseases (hemophilia, inflammatory and autoimmune illnesses, hereditary metabolic diseases, etc.). The turnover per source of income can be broken down as follows:
- sales of products (87.3%);
- royalties (9.6%);
- sales of sub-contracted manufactured products...
Notations Surperformance© of Swedish Orphan Biovitrum AB
Trading Rating : Investor Rating :
All news about SWEDISH ORPHAN BIOVITRUM AB
News in other languages on SWEDISH ORPHAN BIOVITRUM AB
2020 SWEDISH ORPHAN BIOVITRUM AB : chute après son étude sur l’Avatrombopag2020 AVIS D'ANALYSTES DU JOUR : Altice, AXA, Givaudan, Ipsen, Logitech, Proximus, Som..2020 AVIS D'ANALYSTES DU JOUR : BNP Paribas, Boiron, Givaudan, Heineken, Swedish Orph..2020 SWEDISH ORPHAN BIOVITRUM : Veröffentlichung des Halbjahresergebnisses2020 SWEDISH ORPHAN BIOVITRUM : publication des résultats semestriels
Analyst Recommendations on SWEDISH ORPHAN BIOVITRUM AB
Chart SWEDISH ORPHAN BIOVITRUM AB
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SWEDISH ORPHAN BIOVITRUM AB
Short Term Mid-Term Long Term Trends Bearish Bearish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
8
Average target price
213,50 SEK
Last Close Price
163,30 SEK
Spread / Highest target
59,2%
Spread / Average Target
30,7%
Spread / Lowest Target
7,16%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
